Enterprise News

Capital Increase — $100 million for Market Development in China


Since 2013, HSIEHS BIOTECH has maintained a momentum of stable and rapid development in China market. In January 2018, HSIESH BIOTECH (HANGZHOU) CO. LTD. has successfully completed the capital increase by $100 million. HSIEHS BIOTECH (SINGAPORE) PTE. LTD. holds a 100% stake in the Hangzhou company. 


During the past five years, HSIESH BIOTECH has made great achievements in terms of its sales and product development, the company has confidence in China’s investment environment and policy. This capital increase will not only expand the business layouts and investment opportunities, but also improve the market competitiveness and profitability of the company, which has laid a good foundation for the regional business in Asia.